Westfaelische Wilhelms Universitaet Muenster

At Westfaelische Wilhelms Universitaet Muenster, clinical research in cardiovascular disease focuses on improving outcomes for people with atherosclerotic cardiovascular disease, cardiomyopathy, and heart failure. These studies are designed to test new treatment approaches, refine risk reduction strategies, and better understand how to protect heart and kidney function in complex patients.

• Testing new therapies for advanced or metastatic renal cell carcinoma and atherosclerotic cardiovascular disease
• Evaluating treatments for transthyretin-mediated amyloid cardiomyopathy and related cardiac symptoms
• Studying ways to reduce cardiovascular risk and improve long-term outcomes

Work in this area reflects the site’s strong focus on coronary care, heart failure, and vascular medicine, with an emphasis on practical benefits for patients facing serious chronic disease.

Research in digestive system diseases at this site includes studies in cirrhosis, primary biliary cholangitis, hepatic encephalopathy, cholestatic pruritus, and polycystic liver disease. The main goal is to improve symptom control, support liver function, and evaluate better options for patients with advanced liver disorders.

• Assessing treatments for itching caused by cholestatic liver disease
• Improving management of hepatic encephalopathy and hepatorenal syndrome
• Validating biomarkers and personalized approaches in cirrhosis with ascites

These trials highlight a broad interest in hepatology, including both symptom relief and more precise treatment selection for people with complex liver disease.

The site conducts extensive studies in cancer, especially lymphoma, leukemia, myelodysplastic neoplasia, melanoma, renal cell carcinoma, and prostate cancer. Research is aimed at comparing new cancer treatments with standard care, improving survival, and expanding options for adults and children with difficult-to-treat disease.

• Testing novel approaches for classical Hodgkin lymphoma, mantle cell lymphoma, and other aggressive B-cell malignancies
• Evaluating treatment strategies for acute myeloid leukemia and acute lymphoblastic leukemia
• Studying therapy effectiveness in prostate cancer, melanoma, and renal cancer

These oncology trials show a strong commitment to both adult and pediatric hematology-oncology, with a focus on better disease control and safer, more effective treatment choices.

Clinical trials in immune-mediated disease at Westfaelische Wilhelms Universitaet Muenster include atopic dermatitis, psoriasis, hidradenitis suppurativa, chronic spontaneous urticaria, vitiligo, and alopecia areata. The research is centered on testing new therapies that may reduce inflammation, improve skin symptoms, and support longer-term disease control.

• Evaluating new treatments for moderate to severe atopic dermatitis and plaque psoriasis
• Studying symptom improvement in chronic spontaneous urticaria and hidradenitis suppurativa
• Assessing therapies for vitiligo and severe alopecia areata

This area combines dermatology and immunology, with trials designed to measure both effectiveness and tolerability in chronic inflammatory conditions.

Research in respiratory disease and related systemic conditions includes studies in systemic sclerosis and lung involvement, with the aim of preserving breathing capacity and slowing functional decline. The trials are focused on evaluating whether new therapies can improve symptoms and help maintain daily function.

• Testing treatments for systemic sclerosis with attention to lung function
• Assessing approaches that may help slow decline in pulmonary capacity
• Exploring better ways to manage fibrotic disease and related complications

These studies bring together pulmonology and rheumatology, reflecting interest in diseases that affect both the lungs and other organs.

The psychiatric research portfolio at this site includes schizophrenia, major depressive disorder, bipolar depression, and related mental disorders. The studies aim to compare intensified treatment strategies with usual care and to improve symptom control after an early treatment failure.

• Evaluating new approaches for schizophrenia spectrum disorders
• Studying treatment response in major depressive disorder and bipolar depression
• Comparing symptom improvement under early-intensified pharmacological treatment versus standard care

This work supports more personalized psychiatric care, with a focus on helping patients who need better control of persistent or recurring symptoms.

Trials in infectious disease and transplant medicine address fungal infections, viral disease, and complications after kidney transplantation or cardiac surgery. The main purpose is to improve prevention, support recovery, and reduce the risk of organ damage in vulnerable patients.

• Studying treatment and prevention of fungal infection in children and adults
• Assessing care for herpes simplex virus detection in critically ill ventilated patients
• Evaluating strategies to protect kidney graft function and reduce post-surgical renal injury

These studies combine infectious diseases, nephrology, and critical care, showing a broad interest in improving outcomes for high-risk patients.

Important work at the site also covers pediatric oncology and cell therapy, including studies in acute lymphoblastic leukemia, aggressive B-cell lymphoma, and graft-versus-host disease. The research is focused on testing innovative treatments, improving response rates, and understanding long-term safety in children and young adults.

• Evaluating CAR-T-cell therapy and related long-term safety
• Studying treatment options for pediatric B-cell malignancies
• Assessing therapies for steroid-refractory acute graft-versus-host disease

This field highlights the site’s role in advancing pediatric hematology-oncology and next-generation immune-based treatments.